ADHD Drug Shortages Draw Attention In Congress, Court
Executive Summary
Lawmakers seek information from Shire, Novartis and the Drug Enforcement Administration as to the reason behind short supplies of some attention deficit/hyperactivity disorder drugs. A legal dispute over supply of an Adderall XR authorized generic is slated for trial in April.
You may also be interested in...
“Comprehensive” Drug Shortage Mitigation Bill Under Development In House
Like the Senate proposal, it could include reimbursement rate adjustments in addition to requiring early notification of shortages by manufacturers, but questions remain about ensuring there are no unintended consequences.
Postmarketing Safety Gets Closer Focus In Latest US FDA Drugs Center Reorganization
Division of Mitigation Assessment and Medication Error Surveillance will be established within the Office of Surveillance and Epidemiology, a change aimed at strengthening postmarketing oversight of opioids and other drugs; new Office of Safety and Clinical Evaluation will be created in Office of Generic Drugs, where Orange Book staff also will get their own division.
‘Frontline’ Essential Workers, Persons 75 Years And Older Prioritized For Second Phase Of COVID Vaccination
Essential workers who cannot work remotely and have high levels of interaction with the public, and individuals ≥75 years old, should get vaccinated ahead of those 65-74 years old and those with comorbid conditions, CDC Advisory Committee on Immunization Practices recommends.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: